TRAP1 and Parkinson disease: TRAP1 could protect mitochondria by reversing cytotoxicity mediated either by α-synuclein, whose accumulation is pathogenic in PD (49) or by alterations in the Parkin/PINK1 axis, which controls mitochondrial homeostasis (50, 51).